Accessibility: Skip TopNav
Amarna and NorthX signature
Henk Streefkerk (CEO Amarna Therapeutics) and Janet Hoogstraate (CEO NorthX Biologics) after finalizing the agreement
Format
JPEG
Source
Amarna Therapeutics
Downloads
Original
Large
Medium
Small